RailTel Corporation of India Ltd. has been awarded a work order from Dredging Corporation of India Limited valued at ₹18,06,20,011 (including tax). The project involves providing seamless offshore internet for DCI vessels & ICCC. The order is domestic in nature and is expected to be executed by January 18, 2026. This new project win enhances the company’s portfolio in the technology and communication sector.

New Work Order Secured

RailTel Corporation of India Ltd. has received a new work order from Dredging Corporation of India Limited for ₹18,06,20,011, inclusive of all taxes. This was confirmed in an official announcement dated September 21, 2025.

Project Details

The work order focuses on providing seamless offshore internet services for DCI vessels and ICCC. Key aspects of the project include:

• Service Type: Provision of Seamless Offshore Internet for DCI vessels & ICCC.
• Nature: Domestic.
• Completion Date: The project is slated for completion by January 18, 2026.

Timeline

The work order was received on September 20, 2025, at 18:41. The project is expected to be completed within the stipulated timeframe.

Source: BSE

Amber Enterprises India Limited announced that its material subsidiary, IL JIN Electronics (India) Private Limited (“ILJIN”), has acquired 100% equity stake in ILJIN Holding Ltd, an Israel-based entity. The acquisition, completed on September 21, 2025, makes ILJIN Holding Ltd a Wholly Owned Subsidiary of ILJIN. This move aims to bolster ILJIN’s strategic international investments and acquisitions by establishing a dedicated investment platform.

Strategic Acquisition Details

IL JIN Electronics (India) Private Limited (“ILJIN”), a material subsidiary of Amber Enterprises India Limited (“Amber”), has successfully acquired 100% ownership of ILJIN Holding Ltd. This acquisition was finalized on September 21, 2025. ILJIN Holding Ltd is a company incorporated in Israel on September 7, 2025.

Terms of the Acquisition

As part of the transaction, ILJIN acquired 100 ordinary shares of ILJIN Holding from Mr. Gary Sussman, the previous shareholder, representing all of the shareholding. Consequently, ILJIN Holding Ltd is now a Wholly Owned Subsidiary of ILJIN and a Step-down Wholly Owned Subsidiary of Amber Enterprises India Limited.

Purpose of ILJIN Holding Ltd

ILJIN Holding Ltd was established as a Special Purpose Vehicle (SPV) to function as a dedicated investment platform for ILJIN. Its primary purpose is to support and facilitate ILJIN’s strategic international investments and acquisitions. This acquisition aligns with ILJIN’s strategy for international growth and investment opportunities.

Rationale for the Acquisition

The acquisition of ILJIN Holding Ltd is aimed at streamlining and enhancing ILJIN’s ability to pursue strategic international investments. By establishing a dedicated investment platform, ILJIN can more effectively manage and execute its global investment strategies. This move is expected to strengthen ILJIN’s position in the international market and support its long-term growth objectives.

Source: BSE

Indian Railway Catering and Tourism Corporation (IRCTC) has announced a reduction in the Maximum Retail Price (MRP) of its Rail Neer bottled water. This revision is due to the decrease in Goods and Services Tax (GST) on packaged drinking water from 18% to 5%. The new prices are effective from September 22, 2025.

Rail Neer Price Reduction

The Indian Railway Catering and Tourism Corporation (IRCTC) has announced a revision in the Maximum Retail Price (MRP) of Rail Neer bottles. This change follows a reduction in the Goods and Services Tax (GST) on packaged drinking water, which has decreased from 18% to 5%.

New Pricing Details

Effective September 22, 2025, the revised MRP for Rail Neer bottles are as follows:

* 1000 ml Bottle: ₹14 (previously ₹15)
* 500 ml Bottle: ₹9 (previously ₹10)

This price revision reflects the reduced tax burden, and IRCTC is passing the benefit directly to railway passengers. The company stated that this revision is in accordance with government directives.

Source: BSE

Wipro Limited celebrated the 20th edition of the Spirit of Wipro Run, uniting over 62,000 participants worldwide. The event, held across more than 100 cities including Bengaluru, New Jersey and Dubai, promotes wellbeing and community engagement. The run included employees, families, clients and partners. The registrations facilitated a corporate contribution to Wipro Cares, supporting over 85 non-profit organizations.

Global Participation and Purpose

Wipro Limited marked a milestone by hosting the 20th Spirit of Wipro Run. This year’s event saw the participation of over 62,000 individuals globally, consisting of Wipro employees, their families, friends, and valued clients and partners. The event was held in over 100 cities worldwide.

Leadership Involvement

Rishad Premji, Executive Chairman, Wipro Limited, inaugurated the event at Sree Kanteerava Stadium in Bengaluru. Srini Pallia, Chief Executive Officer and Managing Director, Wipro Limited, participated in the run in East Brunswick, New Jersey.

Community and Social Impact

The Spirit of Wipro Run fosters unity within global communities. Each registration results in a corporate contribution via Wipro Cares, benefiting over 85 non-profit organizations. These partnerships focus on healthcare initiatives, access to education for underprivileged communities, and environmental sustainability. A custom-built platform manages registrations, ensuring a seamless participant experience.

Run Coverage

The Spirit of Wipro Run took place in over 100 locations worldwide, including key cities such as Bengaluru, New Jersey, Toronto, London, Zurich, Dubai, Singapore, and Sydney. In Bengaluru, the Spirit of Wipro Run was integrated with the Wipro Bengaluru Marathon. The 12th edition of the Marathon featured over 35,000 runners. In 2025, Wipro marked its third consecutive year as the title sponsor of the Wipro Bengaluru Marathon.

Source: BSE

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the USFDA for its oncology injectable manufacturing facility in SEZ1, Ahmedabad. The inspection, conducted from June 9th to 18th, 2025, resulted in the facility being classified as Voluntary Action Indicated (VAI). This is a revision from the previous classification of Official Action Indicated (OAI) in June 2024.

USFDA Inspection Outcome

Zydus Lifesciences announced that its oncology injectable manufacturing facility located in SEZ1, Ahmedabad, has received an Establishment Inspection Report (EIR) from the USFDA. This follows a GMP follow-up inspection that occurred between June 9th and June 18th, 2025.

Voluntary Action Indicated

The USFDA has classified the facility as Voluntary Action Indicated (VAI). This new classification revises an earlier classification in June 2024. Previously, the facility was classified as Official Action Indicated (OAI), however it now falls under the VAI category.

Source: BSE

Bajaj Holdings & Investment Limited communicated with shareholders on September 19, 2025, regarding Tax Deduction at Source (TDS) on dividend income. The communication detailed the process and documentation needed for claiming exemption from tax deduction on dividend. The company has requested shareholders to submit necessary documents by October 1, 2025, to avail applicable TDS provisions.

Dividend Income Tax Information

Bajaj Holdings & Investment Limited informed shareholders about the tax implications on dividend income as per the Income Tax Act, 1961. A detailed communication was dispatched on September 19, 2025, to those holding shares as of September 12, 2025, outlining the necessary procedures and documentation for claiming tax exemptions on dividends.

Key Details for Shareholders

The company requires shareholders to provide or update specific details to comply with TDS provisions. These include a valid Permanent Account Number (PAN), residential status for the financial year 2025-26, and shareholder category. Also required are email addresses and bank account details.

TDS Rates and Required Submissions

Tax will be deducted at source under section 194 of the IT Act. Individual shareholders with aggregate dividend income up to ₹10,000 during the financial year may face 0% TDS. Shareholders need to submit Form 15G or Form 15H for applicable exemptions. Without a valid PAN, or if PAN is unlinked with Aadhaar, a 20% TDS will be applicable.

Non-Resident Shareholder Information

For non-resident shareholders, tax is deducted as per section 195 of the IT Act. The TDS rate is 20% plus applicable surcharge and health & education cess. However, they have the option to be governed by the Double Tax Avoidance Agreement (DTAA) if it’s more beneficial and required documentation is provided.

Important Dates and Information

The deadline for submitting documents or communicating tax determination is October 1, 2025. Shareholders are requested to upload the necessary documents with KFin Technologies Limited. The company will email TDS certificates to shareholders post-dividend payment. The company declared an interim dividend of ₹ 65 per equity share of face value of ₹ 10 each, for the financial year ending 31 March 2026.

Source: BSE

Jubilant Pharmova Limited announced that the United States Food and Drug Administration (USFDA) completed its Post-marketing Adverse Drug Experience (PADE) inspection of Jubilant Cadista Pharmaceuticals Inc., USA, on September 19, 2025. The inspection concluded with zero observations, reaffirming Jubilant’s commitment to quality, safety, and compliance. This positive outcome underscores the company’s adherence to stringent regulatory standards.

USFDA Inspection Completion

Jubilant Pharmova Limited announced the successful completion of the United States Food and Drug Administration (USFDA) Post-marketing Adverse Drug Experience (PADE) inspection. The inspection was conducted at Jubilant Cadista Pharmaceuticals Inc., USA, a subsidiary of Jubilant Pharma Limited.

Key Highlights

The inspection, which concluded on September 19, 2025, resulted in zero observations. This outcome highlights Jubilant Pharmova’s dedication to maintaining the highest standards of quality, safety, and compliance in its pharmaceutical operations. The successful completion of the inspection reinforces the company’s commitment to regulatory excellence. The initial announcement was made on September 20, 2025.

About Jubilant Pharma Limited

Jubilant Pharma Limited (JPL), a subsidiary of Jubilant Pharmova, is an integrated global pharmaceutical company. It focuses on manufacturing and supplying Radiopharmaceuticals, Allergy Immunotherapy, and Contract Manufacturing of Sterile Injectables and Non-sterile products. The company operates multiple manufacturing facilities catering to regulated markets, including the USA and Europe.

About Jubilant Pharmova Limited

Jubilant Pharmova Limited is a company with a global presence involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics, and Proprietary Novel Drugs businesses. With facilities catering to regulated markets, the company emphasizes its role as a ‘Partner of Choice’.

Source: BSE

Bandhan Bank has granted 2,96,455 equity stock options to its eligible employees under the ‘Bandhan Bank Employee Stock Option Plan Series 1’ (‘ESOP Series 1‘). These options have a face value of ₹10 each and were granted at a price of ₹167.08 per option. The grant was approved by the Nomination and Remuneration Committee of the Board on September 20, 2025.

ESOP Grant Details

Bandhan Bank granted 2,96,455 ESOPs to eligible employees under the ‘Bandhan Bank Employee Stock Option Plan Series 1’, Tranche 7.

Key Scheme Information

The ‘ESOP Series 1’ has been formulated and approved by the Shareholders. Each option allows the holder to apply for one equity share with a face value of ₹10.

Vesting Schedule

The ESOPs will vest as follows:

• 25% will vest upon completion of one year from the grant date.
• 25% will vest upon completion of two years from the grant date.
• 25% will vest upon completion of three years from the grant date.
• 25% will vest upon completion of four years from the grant date.

Exercise Period

The options must be exercised within a maximum period of five years from their respective vesting dates.

Pricing

The ESOPs have been granted at a price based on the latest available closing price on the National Stock Exchange of India Limited on Friday, September 19, 2025, which was the trading day immediately preceding the grant approval date.

Source: BSE

NBCC (India) Limited has received work orders amounting to ₹117 Crore from Housing and Urban Development Corporation Ltd. (HUDCO). The projects include commercial development in Ghaziabad, development of HUDCO plots in Panchkula, construction in Ahmedabad, and flat reconstruction in New Delhi. A Memorandum of Understanding (MoU) was signed between NBCC and HUDCO on September 19, 2025.

New Project Details

NBCC (India) Limited has announced the acquisition of new projects from Housing and Urban Development Corporation Ltd. (HUDCO) following a Memorandum of Understanding (MoU) signed on September 19, 2025. The total value of these projects is approximately ₹117 Crore.

Project Breakdown

The secured projects encompass a range of construction and development activities:

• Development of Commercial Plot at Kaushambi, Ghaziabad (UP): ₹23.08 Cr
• Development of HUDCO Plot at Panchkula, Haryana: ₹26.92 Cr
• Construction of Additional Blocks at HUDCO Regional Office, Ahmedabad, Gujarat: ₹63.36 Cr
• Reconstruction of Flats at Asian Games Village Complex (AGVC), New Delhi: ₹3.65 Cr

The projects will be executed for HUDCO.

Source: BSE

Atul Auto has appointed M/s. Hardik Hudda & Associates as its secretarial auditor for a term of five years, starting from the financial year 2025-26 and ending in 2029-30. The appointment was approved by shareholders at the 37th Annual General Meeting (AGM) held on September 19, 2025. The firm is a peer-reviewed firm of Practicing Company Secretaries.

Secretarial Auditor Appointment

Atul Auto has officially appointed M/s. Hardik Hudda & Associates as the company’s secretarial auditor. This decision was ratified during the 37th Annual General Meeting (AGM) held on September 19, 2025. The appointment is for a term of five years.

Auditor Term Details

The secretarial audit will cover the financial years from 2025-26 to 2029-30. M/s. Hardik Hudda & Associates (Membership No. A39621, CP No. 14697) is a firm of Practicing Company Secretaries based in Ahmedabad. The firm is registered with the Institute of Company Secretaries of India (ICSI) and has over 10 years of professional experience.

Source: BSE